{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:00:07Z","timestamp":1793307607725,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0919-9","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T09:53:14Z","timestamp":1537782794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database \u2013 Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014"],"prefix":"10.1186","volume":"18","author":[{"name":"On behalf of NCVD-PCI investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7451-1802","authenticated-orcid":false,"given":"Muhammad Dzafir","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisarah","family":"Jalalonmuhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid","family":"Azhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeevitha","family":"Mariapun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Vin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Zainal Abidin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Azman","family":"Wan Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Syadi Mahmood","family":"Zuhdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"issue":"7","key":"919_CR1","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1681\/ASN.2005101085","volume":"17","author":"T Marcello","year":"2006","unstructured":"Marcello T, Natasha W, Bruce C, Andrew H, Chris R, Mei F, et al. Chronic kidney disease and mortality risk: a systemic review. J Am Soc Nephrol. 2006;17(7):2034\u201347.","journal-title":"J Am Soc Nephrol"},{"key":"919_CR2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1681\/ASN.V551231","volume":"5","author":"EB Wendy","year":"1994","unstructured":"Wendy EB, Friedrich KP, Elizabeth AM, Robert AW. Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol. 1994;5:1231\u201342.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"919_CR3","first-page":"473","volume":"13","author":"JS Al Wakeel","year":"2002","unstructured":"Al Wakeel JS, Mitwalli AH, Al Mohaya S, Abu-Aisha H, Tarif N, Malik GH, et al. Morbidity and mortality in ESRD patients on dialysis. Saudi J Kidney Dis Transpl. 2002;13(4):473\u20137.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"919_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1523-1755.2000.00816.x","volume":"57","author":"A Ojo","year":"2000","unstructured":"Ojo A, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int. 2000;57:307\u201313.","journal-title":"Kidney Int"},{"issue":"6","key":"919_CR5","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.ahj.2010.08.007","volume":"160","author":"AP Amin","year":"2010","unstructured":"Amin AP, Spertus JA, Reid KJ, Lan X, Buchanan DM, Decker C, et al. The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality. Am Heart J. 2010;160(6):1065\u201371.","journal-title":"Am Heart J"},{"issue":"13","key":"919_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa041365","volume":"351","author":"NS Anavekar","year":"2004","unstructured":"Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285\u201395.","journal-title":"N Engl J Med"},{"key":"919_CR7","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296\u2013305.","journal-title":"N Engl J Med"},{"issue":"11","key":"919_CR8","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1038\/sj.ki.5001934","volume":"70","author":"D Charytan","year":"2006","unstructured":"Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int. 2006;70(11):2021\u201330.","journal-title":"Kidney Int"},{"key":"919_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002772","volume":"5","author":"MA Navarro","year":"2016","unstructured":"Navarro MA, Gosch KL, Spertus JA, Rumsfeld JS, Ho PM. Chronic kidney disease and health status outcomes following acute myocardial infarction. J Am Heart Assoc. 2016;5:e002772.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"919_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","volume":"121","author":"CS Fox","year":"2010","unstructured":"Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease. A report from the National Cardiovascular Data Acute Coronary Treatment and intervention outcomes network registry. Circulation. 2010;121(3):357\u201365.","journal-title":"Circulation"},{"key":"919_CR11","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1093\/eurheartj\/eht220","volume":"34","author":"MB Thalia","year":"2013","unstructured":"Thalia MB, Kristine H, Jonas BO, Christian TP, Mette M, Anne-Lise K. Less use of standard guideline-based treatment of myocardial infarction in patients with chronic kidney disease: a Danish nation-wide cohort study. Eur Heart J. 2013;34:2916\u201323.","journal-title":"Eur Heart J"},{"issue":"10","key":"919_CR12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.jacc.2015.10.005","volume":"67","author":"GN Levine","year":"2016","unstructured":"Levine GN, O\u2019Gara PT, Bates ER, Blankenship JC, Kushner FG, Ascheim DD, et al. 2015 ACC\/AHA\/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2016;67(10):1235\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"919_CR13","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"PG Steg","year":"2012","unstructured":"Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2012;33(20):2569\u2013619.","journal-title":"Eur Heart J"},{"key":"919_CR14","volume-title":"Annual report of the NCVD-PCI registry, year 2013\u20132014","year":"2016","unstructured":"Wan Ahmad WA, Liew HB, editors. Annual report of the NCVD-PCI registry, year 2013\u20132014. Kuala Lumpur, Malaysia: National Cardiovascular Disease Database; 2016."},{"key":"919_CR15","unstructured":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002; 39: S1-S266."},{"issue":"2","key":"919_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann Intern Med. 2003;139(2):137\u201347.","journal-title":"Ann Intern Med"},{"issue":"6","key":"919_CR17","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089\u2013100.","journal-title":"Kidney Int"},{"key":"919_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/01.CIR.78.2.486","volume":"78","author":"TJ Ryan","year":"1988","unstructured":"Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology\/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous Transluminal coronary angioplasty). Circulation. 1988;78:486\u2013502.","journal-title":"Circulation"},{"key":"919_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","volume":"137","author":"RS Wright","year":"2002","unstructured":"Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002;137:563\u201370.","journal-title":"Ann Intern Med"},{"key":"919_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","volume":"137","author":"MG Shlipak","year":"2002","unstructured":"Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002;137:555\u201362.","journal-title":"Ann Intern Med"},{"key":"919_CR21","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","volume":"24","author":"M Moscucci","year":"2003","unstructured":"Moscucci M, Fox KA, Cannon CP, Klein W, Lopez-Sendon J, Montalescot G, et al. Predictors of major bleeding in acute coronary syndromes: the global registry of acute coronary events (GRACE). Eur Heart J. 2003;24:1815\u201323.","journal-title":"Eur Heart J"},{"key":"919_CR22","first-page":"2015","volume-title":"National Health and morbidity survey 2015 (NHMS 2015)","author":"Institute for Public Health (IPH)","year":"2015","unstructured":"Institute for Public Health (IPH). National Health and morbidity survey 2015 (NHMS 2015). Vol. II: Non-Communicable Diseases, Risk Factors & Other Health Problems; 2015. p. 2015."},{"key":"919_CR23","unstructured":"Goh BL, Ong LM. (Eds). Twenty second Report of the Malaysian Dialysis and Transplant 2014, Kuala Lumpur 2015."},{"key":"919_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008188","volume":"5","author":"LS Sederholm","year":"2015","unstructured":"Sederholm LS, Alfredsson J, Szummer K, Fredrikson M, Swahn E. Prevalence and prognostic impact of chronic kidney disease in STEMI from a gender perspective: data from the SWEDEHEART register a large Swedish prospective cohort. BMJ Open. 2015;5:e008188.","journal-title":"BMJ Open"},{"issue":"6","key":"919_CR25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.5144\/0256-4947.2013.572","volume":"33","author":"AS Zuhdi","year":"2013","unstructured":"Zuhdi AS, Mariapun J, Mohd Hairi NN, Wan Ahmad WA, Imran ZA, Undok AW, et al. Young coronary artery disease in patients undergoing percutaneous coronary intervention. Ann Saudi Med. 2013;33(6):572\u20138.","journal-title":"Ann Saudi Med"},{"issue":"9","key":"919_CR26","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/heart.89.9.1003","volume":"89","author":"J J Santopinto","year":"2003","unstructured":"Santopinto JJ, Fox KAA, Goldberg RJ, Budaj A, Pinero G, Avezum A, et al. and on behalf of the GRACE Investigators. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: Findings from the global registry of acute coronary events (GRACE). Heart. 2003 Sep; 89(9): 1003\u20131008.","journal-title":"Heart"},{"key":"919_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71\u201386.","journal-title":"BMJ"},{"issue":"6","key":"919_CR28","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2215\/CJN.04371206","volume":"2","author":"J Shepherd","year":"2007","unstructured":"Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, et al. Treating to New Targets Investigators. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol. 2007;2(6):1131.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"919_CR29","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1681\/ASN.2013090965","volume":"25","author":"R Haynes","year":"2014","unstructured":"Haynes R, Lewis D, Emberson J, Reith C, Agodoa L, Cass A, et al. SHARP Collaborative Group. Effects of lowering LDL cholesterol on progression of kidney disease. J Am Soc Nephrol. 2014;25(8):1825.","journal-title":"J Am Soc Nephrol"},{"key":"919_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360:7\u201322.","journal-title":"Lancet"},{"issue":"9215","key":"919_CR31","first-page":"1575","volume":"355","author":"MD Flather","year":"2000","unstructured":"Flather MD, Yusuf S, K\u00f8ber L, Pfeffer M, Hall A, Murray G, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group Lancet. 2000;355(9215):1575.","journal-title":"ACE-Inhibitor Myocardial Infarction Collaborative Group Lancet"},{"key":"919_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jacc.2007.10.001","volume":"51","author":"EM Antman","year":"2008","unstructured":"Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC\/AHA 2004 guidelines for the Management of Patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines (writing group to review new evidence and update the ACC\/AHA 2004 guidelines for the Management of Patients with ST-elevation myocardial infarction). J Am Coll Cardiol. 2008;51:210\u201347.","journal-title":"J Am Coll Cardiol"},{"key":"919_CR33","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, K\u00f8ber L, Maggioni AP, et al. Valsartan in acute myocardial infarction trial investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349:1893\u2013906.","journal-title":"N Engl J Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0919-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0919-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0919-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T11:46:07Z","timestamp":1662119167000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0919-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0919-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"6 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The NCVD-PCI is registered in the National Medical Research Register of Malaysia (ID: NMRR-07-20-250) and received ethical approval from the Ministry of Health Medical Research and Ethics committee. Consent from individual patients was not necessary as the data collected were anonymized. Each patient will receive a unique identification number recorded in the registry.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"184"}}